PharmaMind Autonomous Lab Completes Full-Process Anti-Cancer Compound Discovery in 47 Days
AI drug discovery platform PharmaMind independently completed the full discovery process for an EGFR-mutant non-small cell lung cancer candidate compound in 47 days without human intervention, reducing the timeline by 85%.